Strategies to Expand Black and Hispanic Representation in Pediatric Clinical Trials

Participation in pediatric clinical trials remains strikingly low among Black and Hispanic families, limiting the broader applicability of novel medical treatments for children of color. Because therapies evaluated in racially homogenous trial cohorts may not account for diverse biological or environmental factors, improving trial representation is essential to advancing pediatric health equity.

A newly published study in the Journal of Clinical and Translational Science offers evidence-based strategies to address these enrollment disparities. Researchers evaluated a series of structural, cultural, and communicative adaptations designed to build trust and eliminate barriers for underrepresented pediatric patients and their families.

Addressing Structural Barriers to Trial Access

Historically, structural obstacles have prevented many Black families from participating in pediatric research. Financial burdens—including lost wages, travel costs, and child care challenges—frequently deter eligible families from enrolling or remaining in long-term clinical studies.

The research highlights several key interventions to mitigate these obstacles:

• Flexible Scheduling and Decentralized Care: Offering weekend or evening appointments and utilizing remote monitoring tools reduces the burden on working parents.
• Direct Financial Support: Providing non-coercive travel vouchers, meal stipends, and childcare support helps neutralize the out-of-pocket costs associated with trial participation.
• Community-Based Recruitment: Conducting outreach through trusted local institutions—such as community health centers, churches, and neighborhood organizations—helps meet families in familiar environments.

Cultivating Trust and Cultural Relevance

Beyond logistical adjustments, the study emphasizes the necessity of culturally grounded communication. Historical exploitation and ongoing biases in the healthcare system have fostered deep-seated mistrust among Black communities regarding medical experimentation. Rebuilding that trust requires pediatric researchers to adopt transparent, patient-centered approaches.

The findings indicate that pediatric research teams must prioritize plain-language consent materials and engage culturally competent patient navigators. When clinical staff share similar cultural backgrounds or receive robust training in health equity, families report feeling more informed and respected throughout the decision-making process.

The Vital Role of Diverse Researchers

Increasing pediatric trial diversity is deeply tied to expanding representation within the clinical research workforce. HBCU medical schools and research institutions play a pivotal role in preparing Black physicians, clinical trial coordinators, and principal investigators who understand the specific needs of minoritized communities.

When Black medical professionals lead clinical trials, research design inherently becomes more responsive to the lived experiences of diverse populations. Increasing financial resources and infrastructure for HBCU-led research centers ensures that pediatric clinical trials are designed with equity at their core, ultimately driving better health outcomes for the next generation.